medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Number 6

<< Back Next >>

Rev Invest Clin 2011; 63 (6)

Intercellular adhesion molecules and mortality for sepsis in infants younger than 1 year of life

Sosa-Bustamante GP, Amador-Licona N, Barbosa-Sabanero G, Guízar-Mendoza JM, López-Briones S, Mulgado-Águas CI, Torres-Pedroza A

Language: English
References: 24
Page: 601-606
PDF size: 126.26 Kb.


ABSTRACT

Background. Adhesion molecules in sepsis syndrome are correlated with the severity of illness and may be considered as predictors of survival outcome in adults. However, only few studies have been performed in infants and none using international criteria for sepsis. Objective. To determine whether adhesion molecules during the first 7 days of the disease could predict sepsis outcome and its severity. Material and methods. We performed a prospective study in 88 infants with sepsis and 30 controls. Soluble intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and E-selectin levels were determined at days 1, 3 and 7 of follow-up in those patients with sepsis and only one determination in the control group. The main outcome measure was mortality during 10 days of monitoring. Results. Positive hemoculture was reported in 64(72.7%). ICAM-1, VCAM-1, and E-selectin levels were higher in the group of sepsis than in the control group. However, no association was found between ICAM-1, VCAM-1 or E-selectin levels with sepsis severity. Mortality linked to sepsis was observed in 9 patients (10.2%). In the logistic regression analysis, those variables positively associated with mortality were the increase in ICAM-1 levels › 250 ng/mL between day 1 to 3, number of amines and the baseline severity of sepsis. However, we did not identify in those patients who died a specific pattern in adhesion molecules levels during follow up. Conclusions. ICAM-1 levels, number of amines and severity of sepsis levels predict mortality during 10 days of monitoring in infants younger than 1 year of age with sepsis.


REFERENCES

  1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.

  2. Berger A, Salzer HR, Weninger M, Sageder B, Aspock C. Septicaemia in an Austrian neonatal intensive care unit: a 7-year analysis. Acta Paediatr 1998; 87: 1066-9.

  3. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003; 60: 49-57.

  4. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-69.

  5. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-7.

  6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.

  7. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NP. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994; 22: 651-57.

  8. Kayal S, Jais JP, Aguini N, Chaudiére J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157: 776-84.

  9. Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, Kochanek PM, Carcillo JA. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med 2000; 28: 2600-7.

  10. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA. Soluble E-Selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997; 156: 431-7.

  11. Figueras-Aloy J, Gómez-López L, Rodríguez-Miguélez JM, Salvia-Roiges MD, Jordán-García I, Ferrer-Codina I, et al. Serum Soluble ICAM-1, VCAM-1, L-Selectin, and P-Selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. Am J Perinatol 2007; 24: 333-8.

  12. Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996; 22: 122-8.

  13. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatric Crit Care Med 2005; 6: 2-8.

  14. Watson RS, Carcillo JA, Linde-Zwirble WT, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 67: 695-701.

  15. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care 2008; 12(Suppl. 4): S4.

  16. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12.

  17. Marui N, Offermann MK, Swerlick R. Vascular cell adhesion molecule-1(VCAM-1) gene transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial cells. J Clin Invest 1995; 92: 1866-74.

  18. Krueger M, Heizmann A, Nauck M. Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome. Intensive Care Med 2007; 33: 359-63.

  19. Lo SK, Lee S, Ramos RA, Lobb R, Rosa M, Chi-Rosso G, et al. Endothelial leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J Exp Med 1991; 173: 1493-500.

  20. Barnett CC, Moore EE, Moore FA, Biffl WL, Partrick DA. Soluble intercellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD18. Surgery 1996; 120: 395-401.

  21. Springer T. Adhesion receptors of the immune system. Nature 1990; 346: 425-33.

  22. Carlos T, Harlam JM. Membrane protein involved in phagocyte adherence to endothelium. Immunol Rev 1990; 114: 5-28.

  23. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-93.

  24. Ulich TR, Howard SC, Remick DG, Yi ES, Collins T, Guo K, et al. Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation. Inflammation 1994; 18: 389-98.




2020     |     www.medigraphic.com